30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Vereinigte Staaten Healthcare Sector Insider Trading Activity

Verfolgen Sie Insider-Käufe und -Verkäufe bei Vereinigte Staaten Healthcare-Aktien. Sehen Sie, welche Führungskräfte kaufen, die Netto-Inside-Aktivität und % des gehandelten Free Floats über 2,062 Unternehmen.
Die in diesem Screen bereitgestellten Informationen dienen nur zu Informationszwecken und stellen keine Finanzberatung dar. Wir befürworten keine spezifische Investition basierend auf diesen Kriterien.
Unternehmen
Daten
Abonnieren, um auf vollständige Daten zuzugreifen
Unternehmen Geschäftsfeld Marktkapitalisierung ($) # Insidern mit Nettokäufen Nettowert gekauft ($) % des Streubesitzes gekauft % der von Insidern gehaltenen Aktien
Pharmaceuticals & Medical Research Mega (1.0tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (589.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (429.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Mega (377.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (309.8bn) 0 Keine Aktivität — 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (167.0bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (155.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (154.2bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (150.4bn) 0 Keine Aktivität — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (146.5bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (130.0bn) -1–5 -$100M+ -0–15% 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (120.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (116.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (115.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (112.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (107.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (97.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (96.7bn) 0 Keine Aktivität — 15–50%
Healthcare Services Large (90.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Keine Aktivität — —
Pharmaceuticals & Medical Research Large (73.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (72.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (67.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (65.3bn) -1–5 -$100M+ -15–50% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Keine Aktivität — 0–15%
US Cencora Inc (COR)
Healthcare Services Large (54.7bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (50.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.1bn) 0 Keine Aktivität — 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (43.1bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (40.1bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (39.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (39.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (37.7bn) -1–5 -$100K–$1M -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (36.2bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (36.1bn) 0 Keine Aktivität — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (34.1bn) 1–5 $100K–$1M 0–15% 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (30.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (29.9bn) 0 Keine Aktivität — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (29.8bn) 0 Keine Aktivität — 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (28.2bn) 0 Keine Aktivität — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (27.8bn) 6–10 $1M–$10M 0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (27.0bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Keine Aktivität — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (25.0bn) -1–5 -$100M+ -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.9bn) -1–5 -$10M–$100M -0–15% 15–50%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (21.7bn) 0 Keine Aktivität — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (21.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (21.4bn) 0 Keine Aktivität — 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Keine Aktivität — 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (18.2bn) -11–20 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (17.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Keine Aktivität — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (16.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (15.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (14.0bn) 0 Keine Aktivität — 0–15%
US DaVita Inc (DVA)
Healthcare Services Large (13.7bn) -6–10 -$100M+ -0–15% 50%+
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (13.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.3bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (13.1bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 Keine Aktivität — 15–50%
Healthcare Services Large (12.9bn) 0 Keine Aktivität — 15–50%
US Penumbra Inc (PEN)
Healthcare Services Large (12.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (12.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (12.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (11.7bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (11.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (11.5bn) -1–5 -$100K–$1M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 Keine Aktivität — 0–15%
US Revvity Inc (RVTY)
Healthcare Services Large (11.2bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Large (10.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (10.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (10.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (10.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Insulet Corp (PODD)
Healthcare Services Large (10.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (10.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Nuvalent Inc (NUVL)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 Keine Aktivität — 0–15%
Healthcare Services Mid (9.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Mid (9.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 Keine Aktivität — 15–50%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 Keine Aktivität — 0–15%